Research Use Only - Not for human consumption. 18+ only.
Research CompoundCardiovascular HealthSubcutaneous

Adamax

A cardioprotective and tissue repair peptide with anti-inflammatory properties. Currently in experimental research for cardiovascular and regenerative applications.

Research Status

Research Compound

Early Research

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Supports cardiovascular tissue repair and regeneration
Reduces inflammatory markers in cardiac tissue
Enhances endothelial function and vascular health
Promotes collagen synthesis in damaged tissue
May improve cardiac output and contractility
Supports fibroblast activity and wound healing

Side Effects

Injection site reactions (redness, mild swelling, itching)
CommonMild

Typically resolves within 1–2 hours. Rotate injection sites to minimize recurrence. Apply ice if swelling persists. Ensure proper injection technique and sterile needle use.

Transient headache
UncommonMild

May occur within hours of injection. Usually self-resolving. Ensure adequate hydration and consider timing injection before bed if headaches are bothersome.

Mild fatigue or lethargy
UncommonMild

Reported in early research; typically resolves within 24 hours. Monitor energy levels during the first week of use.

Localized lipodystrophy (fat loss or thickening at injection site)
UncommonModerate

Develops with repeated injections at the same site. Prevent by rotating injection sites systematically. If lipodystrophy develops, discontinue injections at that site for 4–6 weeks.

Allergic reaction (rash, urticaria, angioedema)
RareSerious

Seek immediate medical attention if severe swelling of face, lips, or throat occurs. Discontinue use and do not re-administer. May indicate peptide hypersensitivity.

Dizziness or lightheadedness
RareMild

May occur if injected while standing. Sit or lie down during injection to prevent falls. Resolve within minutes.

Dosing Reference

ParameterValue
Dose range100-300 mcg
Frequency1x daily
TimingAny time of day
RouteSubcutaneous

Research compound with very limited human data. Start at 100 mcg and assess tolerance before increasing. Dosing based on preliminary animal and in vitro studies; clinical protocols not yet established.

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2–8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Adamax is a cardioprotective peptide that acts as a tissue repair and anti-inflammatory agent, primarily through activation of fibroblast growth factor (FGF) signaling pathways and modulation of inflammatory cytokine production. It promotes collagen remodeling, enhances endothelial cell function, and reduces oxidative stress in cardiac tissue, thereby supporting recovery from ischemic injury and chronic inflammatory conditions affecting the cardiovascular system.

Fibroblast Growth Factor (FGF) Signaling

Adamax activates FGF receptor-mediated pathways that promote fibroblast proliferation and collagen synthesis, facilitating tissue repair and remodeling in damaged cardiac tissue

Anti-inflammatory Cytokine Modulation

The peptide reduces pro-inflammatory cytokines (TNF-α, IL-6) while promoting anti-inflammatory mediators (IL-10), reducing systemic inflammation and cardiac tissue damage

Endothelial Function Enhancement

Adamax supports nitric oxide (NO) production and endothelial cell survival, improving vascular reactivity and reducing atherosclerotic progression

Oxidative Stress Reduction

The peptide enhances antioxidant enzyme expression (SOD, catalase) and reduces reactive oxygen species (ROS) accumulation in cardiac myocytes

  • Adamax demonstrates cardioprotective effects in preclinical ischemia-reperfusion injury models
  • The peptide promotes collagen remodeling and reduces cardiac fibrosis in animal studies
  • Anti-inflammatory and pro-angiogenic properties support tissue regeneration and vascular health
  • Mechanism involves FGF pathway activation and modulation of inflammatory mediators
  • Human clinical data are currently unavailable; all evidence is from in vitro and animal models

Track your Adamax research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Adamax is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.